Significant change is coming that will affect how life sciences and healthcare products and services are brought to the market. Patient and consumer expectations are ever higher, the UK government has begun to detail how Brexit will affect the sector and the fallout from the pandemic is influencing how healthcare services are regulated.
Osborne Clarke's Life Sciences and Healthcare regulatory team is delighted to invite you to our Spring 2023 webinar series, focussed on unpicking key regulatory and legal developments to help companies commercialise new products and services.
We hope you'll be able to join us.
Strategies to reduce the liability and regulatory risks that affect innovative products
Innovative products come with a heightened risk of attracting product liability litigation and regulatory investigations. As the EU Medical Device Regulation enters its second year of application, and the UK gears up for its own new regulations, manufacturers need to adapt their strategies to mitigate their risks.
In this webinar Peter Rudd-Clarke, Anna Lundy and Stefanie Lo covered: learning lessons from recent high profile life sciences litigation; capitalising on new laws and regulations to launch innovative products whilst reducing legal risks; and negotiating with your supply chain to allocate liability and regulatory risks.
The future of healthcare regulation in the UK: what you need to know
14 March 2023 | 09:30 - 10:30 GMT
With the NHS in crisis and a transformation in the Care Quality Commission's (CQC's) regulatory approach, major changes are coming to the way that the safety and quality of health and social care is regulated. Reshma Adkin and Alice Babington will share their tips on how this will affect businesses in 2023.
The personalisation of life sciences products
3 May 2023 | 09:30 - 10:30 BST
We are anticipating developments in legislation before the date of this webinar, so further detail on the exact content will be finalised nearer the time.